New Member: Boston Biodevelopment joins MassBio
Trusted regulatory partners to life sciences in the Cambridge-Boston hub and beyond.
Founded in 2009, Boston Biodevelopment is a premium regulatory strategy consulting firm of highly experienced regulatory professionals, including former heads of regulatory affairs, providing world-class hands-on regulatory leadership and management throughout the development and approval of new therapies. We are pleased to affirm our commitment to the biopharma community as a member of MassBio.
Boston Biodevelopment has deep expertise in regulatory affairs across a wide range of therapeutic areas and rare disease in all modalities. Our consultants excel at guiding the regulatory development of biologics, small molecules, cell and gene therapies, and gene editing products through the entire product lifecycle from pre-IND through approval.
Our clients come to us when they need immediately-effective regulatory professionals to help meet their development goals and bring the promise of life science to patients.
